A study co-led by Professor Bart Vanhaesebroeck (UCL Research
Department of Oncology) has found that a class of drug currently used to treat
leukaemia has the unexpected side-effect of boosting immune responses against
many different cancers.
Read: Telegraph,
More: Daily Mail,
Scotsman
Close
